Edwards Pradenas

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Blinded two-year longitudinal evaluation of SARS-CoV-2 antigenemia in long COVID.

Blinded two-year longitudinal evaluation of SARS-CoV-2 antigenemia in long COVID.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 16, 2026

Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID.

Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 16, 2026

Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants.

Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants.

Journal: Protein science : a publication of the Protein Society

Published: October 17, 2025

Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial.

Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial.

Journal: Frontiers in immunology

Published: June 15, 2025

Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study.

Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study.

Journal: Vaccines

Published: May 25, 2025

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Journal: mBio

Published: April 24, 2025

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species.

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species.

Journal: Viruses

Published: April 09, 2025

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Journal: Journal of translational medicine

Published: March 07, 2025

Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Journal: Communications biology

Published: January 15, 2025

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.

Journal: Communications medicine

Published: November 19, 2024

Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.

Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.

Journal: The Journal of infection

Published: September 20, 2024

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

Journal: Journal for immunotherapy of cancer

Published: September 16, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026